Production (Stage)
CareRx Corporation
CHHHF
$1.96
$0.094.81%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.25% | -3.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.25% | -3.25% | |||
| Cost of Revenue | -5.30% | -3.99% | |||
| Gross Profit | -5.13% | -1.45% | |||
| SG&A Expenses | -13.40% | 8.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.69% | -0.71% | |||
| Operating Income | 987.48% | -91.54% | |||
| Income Before Tax | 110.01% | -499.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 109.86% | -507.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 109.86% | -507.73% | |||
| EBIT | 987.48% | -91.54% | |||
| EBITDA | 459.22% | -88.41% | |||
| EPS Basic | 109.51% | -497.73% | |||
| Normalized Basic EPS | 139.13% | -560.00% | |||
| EPS Diluted | 109.13% | -497.73% | |||
| Normalized Diluted EPS | 137.68% | -560.00% | |||
| Average Basic Shares Outstanding | 2.95% | 1.41% | |||
| Average Diluted Shares Outstanding | 6.98% | 1.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||